{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:36:51Z","timestamp":1789875411444,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s13277-015-4689-z","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:16:32Z","timestamp":1453335392000},"page":"9625-9633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Keqiang","family":"huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,21]]},"reference":[{"issue":"5","key":"4689_CR1","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3892\/or.2013.2309","volume":"29","author":"S Zhang","year":"2013","unstructured":"Zhang S, Feng XL, Shi L, Gong CJ, He ZJ, Wu HJ, et al. Genome-wide analysis of DNA methylation in tongue squamous cell carcinoma. Oncol Rep. 2013;29(5):1819\u201326.","journal-title":"Oncol Rep"},{"issue":"4","key":"4689_CR2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1368-8375(99)00008-1","volume":"35","author":"GP Feaver","year":"1999","unstructured":"Feaver GP. Oral cancer in the UK: to screen or not to screen. Oral Oncol. 1999;35(4):450.","journal-title":"Oral Oncol"},{"issue":"12","key":"4689_CR3","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archotol.1996.01890240021006","volume":"122","author":"S Atula","year":"1996","unstructured":"Atula S, Grenman R, Laippala P, Syrjanen S. Cancer of the tongue in patients younger than 40 years. A distinct entity? Arch Otolaryngol Head Neck Surgery. 1996;122(12):1313\u20139.","journal-title":"Arch Otolaryngol Head Neck Surgery"},{"issue":"11","key":"4689_CR4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMra0707975","volume":"359","author":"RI Haddad","year":"2008","unstructured":"Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359(11):1143\u201354.","journal-title":"N Engl J Med"},{"key":"4689_CR5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2350-12-144","volume":"12","author":"B Metzger","year":"2011","unstructured":"Metzger B, Chambeau L, Begon DY, Faber C, Kayser J, Berchem G, et al. The human epidermal growth factor receptor (EGFR) gene in European patients with advanced colorectal cancer harbors infrequent mutations in its tyrosine kinase domain. BMC Med Genet. 2011;12:144.","journal-title":"BMC Med Genet"},{"key":"4689_CR6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1741-7015-10-28","volume":"10","author":"G Chen","year":"2012","unstructured":"Chen G, Kronenberger P, Teugels E, Umelo IA, De Greve J. Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab. BMC Med. 2012;10:28.","journal-title":"BMC Med"},{"issue":"Suppl 2","key":"4689_CR7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/PAT.0000000000000157","volume":"46","author":"N Lindeman","year":"2014","unstructured":"Lindeman N. Keynote lecture: KN01 EGFR and beyond: evolution of molecular classification of lung cancer. Pathology. 2014;46 Suppl 2:S1.","journal-title":"Pathology"},{"issue":"4","key":"4689_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2217\/bmm.15.5","volume":"9","author":"F Caiazza","year":"2015","unstructured":"Caiazza F, Elliott L, Fennelly D, Sheahan K, Doherty GA, Ryan EJ. Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies. Biomark Med. 2015;9(4):363\u201375.","journal-title":"Biomark Med"},{"issue":"10","key":"4689_CR9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00432-013-1470-9","volume":"139","author":"J Mlcochova","year":"2013","unstructured":"Mlcochova J, Faltejskova P, Nemecek R, Svoboda M, Slaby O. MicroRNAs targeting EGFR signalling pathway in colorectal cancer. J Cancer Res Clin Oncol. 2013;139(10):1615\u201324.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"17","key":"4689_CR10","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMe0806778","volume":"359","author":"WA Messersmith","year":"2008","unstructured":"Messersmith WA, Ahnen DJ. Targeting EGFR in colorectal cancer. N Engl J Med. 2008;359(17):1834\u20136.","journal-title":"N Engl J Med"},{"issue":"8","key":"4689_CR11","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(13)70085-8","volume":"14","author":"B Burtness","year":"2013","unstructured":"Burtness B, Bauman JE, Galloway T. Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition. Lancet Oncol. 2013;14(8):e302\u2013309.","journal-title":"Lancet Oncol"},{"key":"4689_CR12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1186\/1471-2407-14-679","volume":"14","author":"DS Tan","year":"2014","unstructured":"Tan DS, Wang W, Leong HS, Sew PH, Lau DP, Chong FT, et al. Tongue carcinoma infrequently harbor common actionable genetic alterations. BMC Cancer. 2014;14:679.","journal-title":"BMC Cancer"},{"issue":"5","key":"4689_CR13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1593\/tlo.12163","volume":"5","author":"KL Mueller","year":"2012","unstructured":"Mueller KL, Powell K, Madden JM, Eblen ST, Boerner JL. EGFR tyrosine 845 phosphorylation-dependent proliferation and transformation of breast cancer cells require activation of p38 MAPK. Transl Oncol. 2012;5(5):327\u201334.","journal-title":"Transl Oncol"},{"issue":"1","key":"4689_CR14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pharmthera.2011.03.012","volume":"131","author":"AK Larsen","year":"2011","unstructured":"Larsen AK, Ouaret D, El Ouadrani K, Petitprez A. Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharmacol Ther. 2011;131(1):80\u201390.","journal-title":"Pharmacol Ther"},{"issue":"30","key":"4689_CR15","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1038\/onc.2011.518","volume":"31","author":"M Lindzen","year":"2012","unstructured":"Lindzen M, Carvalho S, Starr A, Ben-Chetrit N, Pradeep CR, Kostler WJ, et al. A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis. Oncogene. 2012;31(30):3505\u201315.","journal-title":"Oncogene"},{"issue":"8","key":"4689_CR16","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/1078-0432.CCR-10-1993","volume":"17","author":"IS Donev","year":"2011","unstructured":"Donev IS, Wang W, Yamada T, Li Q, Takeuchi S, Matsumoto K, et al. Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer. Clin Cancer Res: Off J Am Assoc Cancer Res. 2011;17(8):2260\u20139.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"issue":"15","key":"4689_CR17","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1200\/JCO.2007.14.8494","volume":"26","author":"LV Sequist","year":"2008","unstructured":"Sequist LV, Martins RG, Spigel D, Grunberg SM, Spira A, Janne PA, et al. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. J Clin Oncol: Off J Am Soc Clin Oncol. 2008;26(15):2442\u20139.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"5","key":"4689_CR18","first-page":"1459","volume":"7","author":"F Ciardiello","year":"2001","unstructured":"Ciardiello F, Caputo R, Bianco R, Damiano V, Fontanini G, Cuccato S, et al. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res: Off J Am Assoc Cancer Res. 2001;7(5):1459\u201365.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"issue":"22","key":"4689_CR19","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1200\/JCO.2005.09.111","volume":"23","author":"F Cappuzzo","year":"2005","unstructured":"Cappuzzo F, Varella-Garcia M, Shigematsu H, Domenichini I, Bartolini S, Ceresoli GL, et al. Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. J Clin Oncol: Off J Am Soc Clin Oncol. 2005;23(22):5007\u201318.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"4","key":"4689_CR20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.18632\/oncotarget.939","volume":"4","author":"Y Ishiguro","year":"2013","unstructured":"Ishiguro Y, Ishiguro H, Miyamoto H. Epidermal growth factor receptor tyrosine kinase inhibition up-regulates interleukin-6 in cancer cells and induces subsequent development of interstitial pneumonia. Oncotarget. 2013;4(4):550\u20139.","journal-title":"Oncotarget"},{"issue":"33","key":"4689_CR21","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1038\/onc.2012.396","volume":"32","author":"S Gusenbauer","year":"2013","unstructured":"Gusenbauer S, Vlaicu P, Ullrich A. HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors. Oncogene. 2013;32(33):3846\u201356.","journal-title":"Oncogene"},{"issue":"6109","key":"4689_CR22","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.1225967","volume":"338","author":"RC Wang","year":"2012","unstructured":"Wang RC, Wei Y, An Z, Zou Z, Xiao G, Bhagat G, et al. Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science. 2012;338(6109):956\u20139.","journal-title":"Science"},{"issue":"2","key":"4689_CR23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.molcel.2013.12.004","volume":"53","author":"TD Martin","year":"2014","unstructured":"Martin TD, Chen XW, Kaplan RE, Saltiel AR, Walker CL, Reiner DJ, et al. Ral and Rheb GTPase activating proteins integrate mTOR and GTPase signaling in aging, autophagy, and tumor cell invasion. Mol Cell. 2014;53(2):209\u201320.","journal-title":"Mol Cell"},{"issue":"12","key":"4689_CR24","first-page":"3917","volume":"118","author":"Z Lu","year":"2008","unstructured":"Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest. 2008;118(12):3917\u201329.","journal-title":"J Clin Invest"},{"issue":"8","key":"4689_CR25","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.0711741105","volume":"105","author":"J Tsai","year":"2008","unstructured":"Tsai J, Lee JT, Wang W, Zhang J, Cho H, Mamo S, et al. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc Natl Acad Sci U S A. 2008;105(8):3041\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"4689_CR26","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1158\/1078-0432.CCR-13-3296","volume":"20","author":"C Liu","year":"2014","unstructured":"Liu C, Lou W, Zhu Y, Nadiminty N, Schwartz CT, Evans CP, et al. Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer. Clin Cancer Res: Off J Am Assoc Cancer Res. 2014;20(12):3198\u2013210.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"issue":"36","key":"4689_CR27","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1038\/onc.2014.25","volume":"33","author":"HG Nguyen","year":"2014","unstructured":"Nguyen HG, Yang JC, Kung HJ, Shi XB, Tilki D, Lara Jr PN, et al. Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model. Oncogene. 2014;33(36):4521\u201330.","journal-title":"Oncogene"},{"issue":"4","key":"4689_CR28","first-page":"191","volume":"68","author":"K Shien","year":"2014","unstructured":"Shien K, Yamamoto H, Soh J, Miyoshi S, Toyooka S. Drug resistance to EGFR tyrosine kinase inhibitors for non-small cell lung cancer. Acta Med Okayama. 2014;68(4):191\u2013200.","journal-title":"Acta Med Okayama"},{"issue":"15","key":"4689_CR29","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1158\/1078-0432.CCR-13-1559","volume":"20","author":"T Yoshida","year":"2014","unstructured":"Yoshida T, Zhang G, Smith MA, Lopez AS, Bai Y, Li J, et al. Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer. Clin Cancer Res: Off J Am Assoc Cancer Res. 2014;20(15):4059\u201374.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4689-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4689-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4689-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T17:43:12Z","timestamp":1567532592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4689-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["4689"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4689-z","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,21]]}}}